Endocrinology Medical News about fine-needle aspiration biopsies

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies
Diagnostic Cytopathology, 10/14/09

Marchevsky AM et al. – A National Cancer Institute (NCI) "Thyroid Fine–Needle Aspiration (FNA) State of the Science Conference" recently proposed standardized nomenclature and "risks of malignancies" associated with various diagnostic categories. The authors evaluated the evidence levels of the data used by NCI to predict malignancy risks and whether those estimates had clinical validity in the patient population. Relative risk and 95% CI calculations suggested that the NCI classification could be simplified into three categories: "benign", "FLUS + neoplasm", and "suspicious + malignant".

<< Previous
BMI and Neuronal Integrity in Healthy, Cognitively Normal...

Next >>
The Blood-Brain Barrier Thyroxine Transporter Organic...